Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Tarek Hassan (NPI 1154367902)

Field	Value
Entity Type	Individual
Organization	Tarek Hassan
Address	3555 W 13 Mile Rd
City	Royal Oak
State	MI
ZIP	48073
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 21, 2006

Payer Source	Total Paid
Medicare	$2.1M
Medicaid	$0

Key Findings

This provider is operating as a retina specialist whose Medicare billing is dominated by intravitreal drug administration and office evaluation services; the top three revenue drivers are J0178 ($1.3M, 61.6% of Medicare revenue), J2778 ($404.7K, 18.9%), and 99214 ($137.9K, 6.5%), which together account for 87.0% of total Medicare revenue. The mix—high-value anti-VEGF drug codes plus a large volume of established-patient E&M—is consistent with a clinic that treats chronic retinal disease with repeated intravitreal injections and follow-up management visits.

Revenue concentration is very high: the precomputed top-3 share of 87.0% signals that a large portion of this provider’s $2.1M in Medicare receipts depends on a small set of treatments, notably aflibercept (J0178) and ranibizumab (J2778). That concentration implies financial sensitivity to changes in drug utilization, reimbursement, or provider-level practice patterns for these agents.

Competitive standing on drug administration is moderate rather than dominant: J0178 ranks #580 of 3204 nationally (82th percentile; described as typical, unremarkable volume) and J2778 ranks #189 of 1208 (84th percentile; typical, unremarkable volume), indicating solid but not market-leading usage of aflibercept and ranibizumab compared with national peers. In short, the provider is a regular, reliable user of anti-VEGF therapies but not a national outlier for those particular codes.

By contrast, office evaluation volume is an outlier: 99214 shows 1.5K claims, $95 avg paid/claim, $137.9K revenue and ranks #3980 of 479517 (99th percentile; extreme outlier, far above typical national volume). This suggests unusually high throughput or sustained, high-intensity follow-up visits for established patients, which materially contributes to the practice’s Medicare revenue profile beyond injectable therapies.

Diagnostic imaging use further supports a retina-focused service line: 92134 appears with 1.5K claims, $30 avg paid/claim, $45.2K revenue and ranks #1515 of 26868 (94th percentile; notably above typical national volume). Elevated OCT utilization aligns with frequent monitoring protocols typical for neovascular retinal disease and complements the high injection volume observed in the drug codes.

The provider bills multiple anti-VEGF agents: J2777 (faricimab) appears with 3.1K claims and $90.5K revenue but is relatively low in national standing (#1808 of 2039, 11th percentile; typical, unremarkable volume) and has a much lower avg paid/claim than aflibercept or ranibizumab. This pattern indicates diversification of injectable agents in the practice, with faricimab contributing measurable claim volume but modest revenue share (4.2% of Medicare revenue) relative to aflibercept and ranibizumab.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2.1M and there is no Medicaid billing on file, so the provider’s revenue exposure is concentrated in Medicare policy, pricing, and patient demand from the Medicare population. This concentration reduces Medicaid-related contracting complexity but increases sensitivity to Medicare reimbursement changes and utilization management efforts for high-cost drug codes.

The provider has an established billing history, with an NPI enumerated on 2006-06-21 (~20 years ago), indicating long tenure in Medicare which may reflect stable referral relationships and a sustained patient panel that supports repeated injection cycles and follow-up care. Long tenure combined with the concentrated revenue mix suggests operational stability but also a potential vulnerability to shifts in anti-VEGF utilization patterns or E&M coding pressure.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

13 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,900	$690	$1.3M
J2778	Injection, ranibizumab, 0.1 mg	2,240	$180	$404.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,450	$100	$137.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,070	$110	$118.1K
J2777	Injection, faricimab‑svoa, 0.1 mg	3,120	$30	$90.5K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	1,510	$30	$45.2K
92201	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	450	$20	$8.1K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	50	$110	$5.4K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	30	$170	$4.8K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	30	$130	$3.1K

Showing 1–10 of 13

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 13 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Tarek Hassan — 2 of 13 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

13 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	15	110	680	$690	$630.2K
J2777	50	60	7,200	$30	$321K
J2778	11	50	730	$180	$240.5K
67028	33	160	440	$90	$57.6K
92014	1,051	1,080	100	$80	$14.8K
99214	37	15,470	80	$80	$11.4K
92235	37	100	40	$100	$7.8K
92134	35	820	60	$30	$7.1K
99205	588	1,680	20	$150	$4.3K
99204	3,353	6,280	30	$110	$4.2K

Showing 1–10 of 13

Related Providers

Other providers that share a Tax Identification Number (TIN) with Tarek Hassan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
William Beaumont Hospital	MI	Hospitalist Physician	$0	$167.9M
Oakwood Healthcare, Inc.	MI	General Acute Care Hospital	$0	$165.3M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$162.4M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$84.8M
Oakwood Ambulatory LLC	MI	Internal Medicine Physician	$0	$66.9M
William Beaumont Hospital	MI	General Acute Care Hospital	$0	$61.5M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Wellstreet Urgent Care Of Michigan	MI	Urgent Care Clinic/Center	$0	$37.5M
Somc Medical Care Foundation, Inc.	OH	Family Medicine Physician	$0	$25.3M
Associated Retinal Consultants, PC	MI	Ophthalmology Physician	$0	$21.1M

Nearby Providers

Other providers in the same ZIP code as Tarek Hassan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Judson Center, Inc.	MI	Community/Behavioral Health Agency	$0	$21.2M
Allergy & Asthma Associates Of Mi PC	MI	Allergy & Immunology Physician	$0	$15.9M
Community Homes, Inc.	MI	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$7.5M
Sandeep Randhawa	MI	Retina Specialist (Ophthalmology) Physician	$7M	$0
American Anesthesiology Of Michigan PC	MI	Anesthesiology Physician	$0	$5.7M
Joshua Robinson	MI	Ophthalmology Physician	$3.7M	$0
Jeremy Wolfe	MI	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Tamer Mahmoud	MI	Retina Specialist (Ophthalmology) Physician	$2.8M	$0
George Williams	MI	Retina Specialist (Ophthalmology) Physician	$2.7M	$0
Kimberly Drenser	MI	Retina Specialist (Ophthalmology) Physician	$2.7M	$0

Tarek Hassan — Billing Profile & Reimbursement Data

Sign up for Tarek Hassan — Billing Profile & Reimbursement Data policy alerts

Tarek Hassan — Billing Profile & Reimbursement Data

Sign up for Tarek Hassan — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References